Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use

Journal of Substance Abuse Treatment

Volumn 13, Issue 3, 1996, Pages 241-248

  Shore, Roy E ^a   Marmor, Michael ^a,c   Titus, Stephen ^a   Des Jarlais, Don C ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

drug injection frequencies; HIV risk reduction counseling; methadone maintenance; temporal changes

Indexed keywords

ALCOHOL; COCAINE; DIAMORPHINE; METHADONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SELF REPORT; SMOKING; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LIFE STYLE; MALE; METHADONE; MIDDLE AGED; NEW YORK CITY; RISK FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0030135630     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(96)00051-7     Document Type: Article

References (21)

1. Blix, O., & Bronbladh, L. (1988). AIDS and IV heroin addicts: The preventive effect of methadone maintenance in Sweden. In 4th International Conference on AIDS, Stockholm.
2. Booth, R.E., Koester, S.K., Reichardt, C.S., & Brewster, J.T. (1993). Quantitative and qualitative methods to assess behavioral change among injection drug users. Drugs & Society, 7, 161-183.
3. Breslow, N., & Day, N. (1980). Statistical methods in cancer research, vol. 1: The analysis of case-control studies. Lyon, France: Intl. Agency for Research on Cancer.
4. Celentano, D.D., Munoz, A., Cohn, S., Nelson, K.E., & Vlahov, D. (1994). Drug-related behavior change for HIV transmission among American injection drug users. Addiction, 89, 1309-1317.
5. Chaisson, R.E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M., & Moss, A. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. Journal of the American Medical Association, 261, 561-565.
6. Dawson, J.D., & Lagakos, S. (1993). Size and power of two-sample tests of repeated measures data. Biometrics. 49, 1022-1032.
7. Des Jarlais, D.C., Friedman, S., Sotheran, J., Wenston, J., Marmor, M., Yancovitz, S., Frank, B., & Mildvan D. (1994). Continuity and change within an HIV epidemic: Injecting drug users in New York City, 1984 through 1992. Journal of the American Medical Association, 271, 121-127.
8. Ewing, J.A. (1984). Detecting alcoholism: The CAGE questionnaire. Journal of the American Medical Association, 252, 1905-1907.
9. Gottheil, E., Sterling, R., & Weinstein, S. (1993). Diminished illicit drug use as a consequence of long-term methadone maintenance. Journal of Addiction Disease, 12, 45-57.
10. Hart, G.J., Carvell, A.L., Woodward, N., Johnson, A.M., Williams, P., & Parry, J.V. (1989). Evaluation of needle exchange in central London: Behaviour change and anti-HIV status over one year. AIDS, 3, 261-265.
11. Lurie, P., & Reingold, A.L. (Eds.) (1993). The public-health impact of needle-exchange programs in the United States and abroad: Summary, conclusions, and recommendations. San Francisco: University of California, Institute for Health Policy Studies.
12. Marmor, M., Des Jartais, D., Cohen, H., Friedman, S., Beatrice, S., Dubin, N., El-Sadr, W., Mildvan, D., Yancovitz, S., Mathur, U., & Holzman, R. (1987). Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS, 1, 39-44.
13. Matthews, J.N.S., Altman, D., Campbell, M., & Royston, P. (1990). Analysis of serial measurements in medical research. British Medical Journal, 300, 230-235.
14. Mayfield, D.G., McLeod, G., & Hall, P. (1974). The CAGE questionnaire: Validation of a new alcoholism screening instrument. American Journal Psychiatry, 131, 1121-1123.
15. McCusker, J., Bigelow, C., Stoddard, A., & Zorn, M. (1994). Human immunodeficiency virus type 1 antibody status and changes in risk behavior among drug users. Annals of Epidemiology, 4, 466-471.
16. Pocock, S.J. (1983). Clinical trials: A practical approach. New York, NY: Wiley.
17. SAS (1988). SAS/STAT users' guide. Cary, NC: SAS Institute.
18. Schoenbaum, E.E., Hartel, D., Selwyn, P., Klein, R., Davenny, K., Rogers, M., Feiner, C., & Friedland, G. (1989). Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine, 321, 874-879.
19. van den Hoek, J.A.R., van Haastrecht, H.J.A., & Coutinho, R.A. (1989). Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. American Journal of Public Health, 79, 1355-1357.
20. Volberding, P.A., Lagakos, S.W., Koch, M.A., Pettinelli, C., Myers, M., Booth, D., Balfour, H., Reichman, R., Bartlett, J., Hirsch, M., Murphy, R., Hardy, D., Soeiro, R., Fischl, M., Bartlett, J., Merigan, T., Hyslop, N., Richman, D., Valentine, F., Corey, L., & NIAID, T.A.C.T.G.o.t. (1990). Zidovudine in asymptomatic human immunodeficiency virus infection. New England Journal of Medicine, 322, 941-949.
21. Wang-Clow, F., Lange, M., Laird, N., & Ware, J. (1995). A simulation study of estimators for rates of change in longitudinal studies with attrition. Statistics in Medicine, 14, 283-297.